As of January 2025, Strides Pharma Science has a market cap of $742.39M. This makes Strides Pharma Science the world's 9182th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $877.48M | 25.25% |
2023 | $700.57M | 85.58% |
2022 | $377.50M | -21.74% |
2021 | $482.39M | -49.09% |
2020 | $947.62M | 142.63% |
2019 | $390.56M | -21.49% |
2018 | $497.44M | -39.92% |
2017 | $827.99M | -22.52% |
2016 | $1.07B | -17.62% |
2015 | $1.30B | 34.31% |
2014 | $965.88M | 166.52% |
2013 | $362.41M | -67.13% |
2012 | $1.10B | 173.16% |
2011 | $403.61M | -10.58% |
2010 | $451.35M | 87.62% |
2009 | $240.57M | 167.60% |
2008 | $89.90M | -68.48% |
2007 | $285.24M | -22.69% |
2006 | $368.95M | 18.73% |
2005 | $310.74M | 45.24% |
2004 | $213.95M | -2.94% |
2003 | $220.44M | 203.56% |
2002 | $72.62M | - |